Your search resulted in multiple matches. Please select a position:

Gencode Genes

AMOTL2 (ENST00000249883.9) at chr3:134355874-134374594 - Homo sapiens angiomotin like 2 (AMOTL2), transcript variant 2, mRNA. (from RefSeq NM_016201)
AMOTL2 (ENST00000515172.1) at chr3:134371064-134373797 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt D6RIC7)
AMOTL2 (ENST00000514516.5) at chr3:134355877-134375479 - Homo sapiens angiomotin like 2 (AMOTL2), transcript variant 4, mRNA. (from RefSeq NM_001363943)
AMOTL2 (ENST00000513145.1) at chr3:134357551-134374445 - Homo sapiens angiomotin like 2 (AMOTL2), transcript variant 3, mRNA. (from RefSeq NM_001278685)
AMOTL2 (ENST00000512955.1) at chr3:134367654-134374560 - angiomotin like 2 (from HGNC AMOTL2)
AMOTL2 (ENST00000511759.1) at chr3:134367753-134374562 - angiomotin like 2 (from HGNC AMOTL2)
AMOTL2 (ENST00000510560.1) at chr3:134370840-134373788 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt D6RCL7)
AMOTL2 (ENST00000506326.1) at chr3:134356185-134366841 - angiomotin like 2 (from HGNC AMOTL2)
AMOTL2 (ENST00000506107.1) at chr3:134371052-134374918 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt D6RBK2)
AMOTL2 (ENST00000505596.1) at chr3:134371000-134371912 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt D6RJA4)
AMOTL2 (ENST00000504234.1) at chr3:134370981-134373794 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt D6RF61)
AMOTL2 (ENST00000502491.1) at chr3:134371335-134374254 - The sequence shown here is derived from an Ensembl  automatic analysis pipeline and should be considered as  preliminary data. (from UniProt D6RFG0)
AMOTL2 (ENST00000422605.6) at chr3:134355877-134374447 - Regulates the translocation of phosphorylated SRC to  peripheral cell-matrix adhesion sites. Required for proper  architecture of actin filaments. Inhibits the Wnt/beta-catenin  signaling pathway, probably by recruiting CTNNB1 to recycling  endosomes and hence preventing its translocation to the nucleus.  Participates in angiogenesis. May play a role in the polarity,  proliferation and migration of endothelial cells. Selectively  promotes FGF-induced MAPK activation through SRC. (from UniProt Q9Y2J4)
SRC (ENST00000373578.6) at chr20:37346154-37406050 - Homo sapiens SRC proto-oncogene, non-receptor tyrosine kinase (SRC), transcript variant 2, mRNA. (from RefSeq NM_198291)
SRC (ENST00000373567.6) at chr20:37383668-37406050 - Non-receptor protein tyrosine kinase which is activated  following engagement of many different classes of cellular  receptors including immune response receptors, integrins and other  adhesion receptors, receptor protein tyrosine kinases, G protein-  coupled receptors as well as cytokine receptors. Participates in  signaling pathways that control a diverse spectrum of biological  activities including gene transcription, immune response, cell  adhesion, cell cycle progression, apoptosis, migration, and  transformation. Due to functional redundancy between members of  the SRC kinase family, identification of the specific role of each  SRC kinase is very difficult. SRC appears to be one of the primary  kinases activated following engagement of receptors and plays a  role in the activation of other protein tyrosine kinase (PTK)  families. Receptor clustering or dimerization leads to recruitment  of SRC to the receptor complexes where it phosphorylates the  tyrosine residues within the receptor cytoplasmic domains. Plays  an important role in the regulation of cytoskeletal organization  through phosphorylation of specific substrates such as AFAP1.  Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1  and to localize to actin filaments. Cytoskeletal reorganization is  also controlled through the phosphorylation of cortactin (CTTN).  When cells adhere via focal adhesions to the extracellular matrix,  signals are transmitted by integrins into the cell resulting in  tyrosine phosphorylation of a number of focal adhesion proteins,  including PTK2/FAK1 and paxillin (PXN). In addition to  phosphorylating focal adhesion proteins, SRC is also active at the  sites of cell-cell contact adherens junctions and phosphorylates  substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1),  and plakoglobin (JUP). Another type of cell-cell junction, the gap  junction, is also a target for SRC, which phosphorylates connexin-  43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing  and phosphorylates RNA-binding proteins such as KHDRBS1. Also  plays a role in PDGF-mediated tyrosine phosphorylation of both  STAT1 and STAT3, leading to increased DNA binding activity of  these transcription factors. Involved in the RAS pathway through  phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated  calcium-activated chloride channel activation. Required for  epidermal growth factor receptor (EGFR) internalization through  phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-  1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization  through phosphorylation and activation of ADRBK1, leading to beta-  arrestin phosphorylation and internalization. Has a critical role  in the stimulation of the CDK20/MAPK3 mitogen-activated protein  kinase cascade by epidermal growth factor. Might be involved not  only in mediating the transduction of mitogenic signals at the  level of the plasma membrane but also in controlling progression  through the cell cycle via interaction with regulatory proteins in  the nucleus. Plays an important role in osteoclastic bone  resorption in conjunction with PTK2B/PYK2. Both the formation of a  SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for  this function. Recruited to activated integrins by PTK2B/PYK2,  thereby phosphorylating CBL, which in turn induces the activation  and recruitment of phosphatidylinositol 3-kinase to the cell  membrane in a signaling pathway that is critical for osteoclast  function. Promotes energy production in osteoclasts by activating  mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on  tyrosine residues, thereby promoting its subsequent  autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine  residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances  DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at  'Tyr-9', 'Tyr-373' and 'Tyr-376'. (from UniProt P12931)
SRC (ENST00000373558.2) at chr20:37384150-37406050 - Non-receptor protein tyrosine kinase which is activated  following engagement of many different classes of cellular  receptors including immune response receptors, integrins and other  adhesion receptors, receptor protein tyrosine kinases, G protein-  coupled receptors as well as cytokine receptors. Participates in  signaling pathways that control a diverse spectrum of biological  activities including gene transcription, immune response, cell  adhesion, cell cycle progression, apoptosis, migration, and  transformation. Due to functional redundancy between members of  the SRC kinase family, identification of the specific role of each  SRC kinase is very difficult. SRC appears to be one of the primary  kinases activated following engagement of receptors and plays a  role in the activation of other protein tyrosine kinase (PTK)  families. Receptor clustering or dimerization leads to recruitment  of SRC to the receptor complexes where it phosphorylates the  tyrosine residues within the receptor cytoplasmic domains. Plays  an important role in the regulation of cytoskeletal organization  through phosphorylation of specific substrates such as AFAP1.  Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1  and to localize to actin filaments. Cytoskeletal reorganization is  also controlled through the phosphorylation of cortactin (CTTN).  When cells adhere via focal adhesions to the extracellular matrix,  signals are transmitted by integrins into the cell resulting in  tyrosine phosphorylation of a number of focal adhesion proteins,  including PTK2/FAK1 and paxillin (PXN). In addition to  phosphorylating focal adhesion proteins, SRC is also active at the  sites of cell-cell contact adherens junctions and phosphorylates  substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1),  and plakoglobin (JUP). Another type of cell-cell junction, the gap  junction, is also a target for SRC, which phosphorylates connexin-  43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing  and phosphorylates RNA-binding proteins such as KHDRBS1. Also  plays a role in PDGF-mediated tyrosine phosphorylation of both  STAT1 and STAT3, leading to increased DNA binding activity of  these transcription factors. Involved in the RAS pathway through  phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated  calcium-activated chloride channel activation. Required for  epidermal growth factor receptor (EGFR) internalization through  phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-  1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization  through phosphorylation and activation of ADRBK1, leading to beta-  arrestin phosphorylation and internalization. Has a critical role  in the stimulation of the CDK20/MAPK3 mitogen-activated protein  kinase cascade by epidermal growth factor. Might be involved not  only in mediating the transduction of mitogenic signals at the  level of the plasma membrane but also in controlling progression  through the cell cycle via interaction with regulatory proteins in  the nucleus. Plays an important role in osteoclastic bone  resorption in conjunction with PTK2B/PYK2. Both the formation of a  SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for  this function. Recruited to activated integrins by PTK2B/PYK2,  thereby phosphorylating CBL, which in turn induces the activation  and recruitment of phosphatidylinositol 3-kinase to the cell  membrane in a signaling pathway that is critical for osteoclast  function. Promotes energy production in osteoclasts by activating  mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on  tyrosine residues, thereby promoting its subsequent  autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine  residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances  DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at  'Tyr-9', 'Tyr-373' and 'Tyr-376'. (from UniProt P12931)
SRC (ENST00000358208.8) at chr20:37382604-37405432 - Non-receptor protein tyrosine kinase which is activated  following engagement of many different classes of cellular  receptors including immune response receptors, integrins and other  adhesion receptors, receptor protein tyrosine kinases, G protein-  coupled receptors as well as cytokine receptors. Participates in  signaling pathways that control a diverse spectrum of biological  activities including gene transcription, immune response, cell  adhesion, cell cycle progression, apoptosis, migration, and  transformation. Due to functional redundancy between members of  the SRC kinase family, identification of the specific role of each  SRC kinase is very difficult. SRC appears to be one of the primary  kinases activated following engagement of receptors and plays a  role in the activation of other protein tyrosine kinase (PTK)  families. Receptor clustering or dimerization leads to recruitment  of SRC to the receptor complexes where it phosphorylates the  tyrosine residues within the receptor cytoplasmic domains. Plays  an important role in the regulation of cytoskeletal organization  through phosphorylation of specific substrates such as AFAP1.  Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1  and to localize to actin filaments. Cytoskeletal reorganization is  also controlled through the phosphorylation of cortactin (CTTN).  When cells adhere via focal adhesions to the extracellular matrix,  signals are transmitted by integrins into the cell resulting in  tyrosine phosphorylation of a number of focal adhesion proteins,  including PTK2/FAK1 and paxillin (PXN). In addition to  phosphorylating focal adhesion proteins, SRC is also active at the  sites of cell-cell contact adherens junctions and phosphorylates  substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1),  and plakoglobin (JUP). Another type of cell-cell junction, the gap  junction, is also a target for SRC, which phosphorylates connexin-  43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing  and phosphorylates RNA-binding proteins such as KHDRBS1. Also  plays a role in PDGF-mediated tyrosine phosphorylation of both  STAT1 and STAT3, leading to increased DNA binding activity of  these transcription factors. Involved in the RAS pathway through  phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated  calcium-activated chloride channel activation. Required for  epidermal growth factor receptor (EGFR) internalization through  phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-  1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization  through phosphorylation and activation of ADRBK1, leading to beta-  arrestin phosphorylation and internalization. Has a critical role  in the stimulation of the CDK20/MAPK3 mitogen-activated protein  kinase cascade by epidermal growth factor. Might be involved not  only in mediating the transduction of mitogenic signals at the  level of the plasma membrane but also in controlling progression  through the cell cycle via interaction with regulatory proteins in  the nucleus. Plays an important role in osteoclastic bone  resorption in conjunction with PTK2B/PYK2. Both the formation of a  SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for  this function. Recruited to activated integrins by PTK2B/PYK2,  thereby phosphorylating CBL, which in turn induces the activation  and recruitment of phosphatidylinositol 3-kinase to the cell  membrane in a signaling pathway that is critical for osteoclast  function. Promotes energy production in osteoclasts by activating  mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on  tyrosine residues, thereby promoting its subsequent  autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine  residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances  DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at  'Tyr-9', 'Tyr-373' and 'Tyr-376'. (from UniProt P12931)

NCBI RefSeq genes, curated subset (NM_*, NR_*, NP_* or YP_*)

NM_016201.3 at chr3:134355345-134374585
NM_001278685.1 at chr3:134355345-134374585
NM_001278683.1 at chr3:134355345-134375417

NCBI RefSeq genes, predicted subset (XM_* or XR_*)

XM_017006582.1 at chr3:134355863-134373794
XM_017006581.1 at chr3:134355863-134373797
XM_006713654.3 at chr3:134355863-134374538
XM_017006580.1 at chr3:134355863-134374918
XM_011512881.1 at chr3:134355863-134374918

RefSeq Genes

AMOTL2 at chr3:134355347-134374447 - (NM_016201) angiomotin-like protein 2 isoform 2
AMOTL2 at chr3:134355345-134375417 - (NM_001278683) angiomotin-like protein 2 isoform 1
AMOTL2 at chr3:134355347-134374447 - (NM_001278685) angiomotin-like protein 2 isoform 3
AMOTL2 at chr3:134355347-134374910 - (NM_001363943) angiomotin-like protein 2 isoform 4

Non-Human RefSeq Genes

Amotl2 at chr3:134355888-134371457 - (NM_019764) angiomotin-like protein 2
Amotl2 at chr3:134355886-134371457 - (NM_031717) angiomotin-like protein 2
amotl2a at chr11:94799476-94866071 - (NM_001080177) angiomotin-like 2a

Basic Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134357551-134374445

Comprehensive Gene Annotation Set from GENCODE Version 31 (Ensembl 97)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134356185-134366841
AMOTL2 at chr3:134357551-134374445
AMOTL2 at chr3:134367654-134374560
AMOTL2 at chr3:134367753-134374562
AMOTL2 at chr3:134370840-134373788
AMOTL2 at chr3:134370981-134373794
AMOTL2 at chr3:134371000-134371912
AMOTL2 at chr3:134371052-134374918
AMOTL2 at chr3:134371064-134373797
AMOTL2 at chr3:134371335-134374254

Basic Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134357551-134374445

Comprehensive Gene Annotation Set from GENCODE Version 29 (Ensembl 94)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134356185-134366841
AMOTL2 at chr3:134357551-134374445
AMOTL2 at chr3:134367654-134374560
AMOTL2 at chr3:134367753-134374562
AMOTL2 at chr3:134370840-134373788
AMOTL2 at chr3:134370981-134373794
AMOTL2 at chr3:134371000-134371912
AMOTL2 at chr3:134371052-134374918
AMOTL2 at chr3:134371064-134373797
AMOTL2 at chr3:134371335-134374254

Basic Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134357551-134374445

Comprehensive Gene Annotation Set from GENCODE Version 28 (Ensembl 92)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134356185-134366841
AMOTL2 at chr3:134357551-134374445
AMOTL2 at chr3:134367654-134374560
AMOTL2 at chr3:134367753-134374562
AMOTL2 at chr3:134370840-134373788
AMOTL2 at chr3:134370981-134373794
AMOTL2 at chr3:134371000-134371912
AMOTL2 at chr3:134371052-134374918
AMOTL2 at chr3:134371064-134373797
AMOTL2 at chr3:134371335-134374254

Basic Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134357551-134374445

Comprehensive Gene Annotation Set from GENCODE Version 27 (Ensembl 90)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134356185-134366841
AMOTL2 at chr3:134357551-134374445
AMOTL2 at chr3:134367654-134374560
AMOTL2 at chr3:134367753-134374562
AMOTL2 at chr3:134370840-134373788
AMOTL2 at chr3:134370981-134373794
AMOTL2 at chr3:134371000-134371912
AMOTL2 at chr3:134371052-134374918
AMOTL2 at chr3:134371064-134373797
AMOTL2 at chr3:134371335-134374254

Basic Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134357551-134374445

Comprehensive Gene Annotation Set from GENCODE Version 26 (Ensembl 88)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134356185-134366841
AMOTL2 at chr3:134357551-134374445
AMOTL2 at chr3:134367654-134374560
AMOTL2 at chr3:134367753-134374562
AMOTL2 at chr3:134370840-134373788
AMOTL2 at chr3:134370981-134373794
AMOTL2 at chr3:134371000-134371912
AMOTL2 at chr3:134371052-134374918
AMOTL2 at chr3:134371064-134373797
AMOTL2 at chr3:134371335-134374254

Basic Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134357551-134374445

Comprehensive Gene Annotation Set from GENCODE Version 25 (Ensembl 85)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134356185-134366841
AMOTL2 at chr3:134357551-134374445
AMOTL2 at chr3:134367654-134374560
AMOTL2 at chr3:134367753-134374562
AMOTL2 at chr3:134370840-134373788
AMOTL2 at chr3:134370981-134373794
AMOTL2 at chr3:134371000-134371912
AMOTL2 at chr3:134371052-134374918
AMOTL2 at chr3:134371064-134373797
AMOTL2 at chr3:134371335-134374254

Basic Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134357551-134374445

Comprehensive Gene Annotation Set from GENCODE Version 24 (Ensembl 83)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134356185-134366841
AMOTL2 at chr3:134357551-134374445
AMOTL2 at chr3:134367654-134374560
AMOTL2 at chr3:134367753-134374562
AMOTL2 at chr3:134370840-134373788
AMOTL2 at chr3:134370981-134373794
AMOTL2 at chr3:134371000-134371912
AMOTL2 at chr3:134371052-134374918
AMOTL2 at chr3:134371064-134373797
AMOTL2 at chr3:134371335-134374254

Basic Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134357551-134374445

Comprehensive Gene Annotation Set from GENCODE Version 23 (Ensembl 81)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134356185-134366841
AMOTL2 at chr3:134357551-134374445
AMOTL2 at chr3:134367654-134374560
AMOTL2 at chr3:134367753-134374562
AMOTL2 at chr3:134370840-134373788
AMOTL2 at chr3:134370981-134373794
AMOTL2 at chr3:134371000-134371912
AMOTL2 at chr3:134371052-134374918
AMOTL2 at chr3:134371064-134373797
AMOTL2 at chr3:134371335-134374254

Basic Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134357551-134374445

Comprehensive Gene Annotation Set from GENCODE Version 22 (Ensembl 79)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134356185-134366841
AMOTL2 at chr3:134357551-134374445
AMOTL2 at chr3:134367654-134374560
AMOTL2 at chr3:134367753-134374562
AMOTL2 at chr3:134370840-134373788
AMOTL2 at chr3:134370981-134373794
AMOTL2 at chr3:134371000-134371912
AMOTL2 at chr3:134371052-134374918
AMOTL2 at chr3:134371064-134373797
AMOTL2 at chr3:134371335-134374254

Basic Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134357551-134374445

Comprehensive Gene Annotation Set from GENCODE Version 20 (Ensembl 76)

AMOTL2 at chr3:134355874-134374594
AMOTL2 at chr3:134355877-134374447
AMOTL2 at chr3:134355877-134375479
AMOTL2 at chr3:134356185-134366841
AMOTL2 at chr3:134357551-134374445
AMOTL2 at chr3:134367654-134374560
AMOTL2 at chr3:134367753-134374562
AMOTL2 at chr3:134370840-134373788
AMOTL2 at chr3:134370981-134373794
AMOTL2 at chr3:134371000-134371912
AMOTL2 at chr3:134371052-134374918
AMOTL2 at chr3:134371064-134373797
AMOTL2 at chr3:134371335-134374254

International Knockout Mouse Consortium Genes Mapped to Human Genome

Amotl2_38008 at chr3:134355348-134374564
Amotl2_42611 at chr3:134355348-134374564

Human Aligned mRNA Search Results

BC011454 - Homo sapiens angiomotin like 2, mRNA (cDNA clone MGC:16955 IMAGE:4181482), complete cds.
BC025981 - Homo sapiens angiomotin like 2, mRNA (cDNA clone IMAGE:3622128), complete cds.
AB023206 - Homo sapiens Amotl2 mRNA for angiomotin like 2, other name:KIAA0989.
AF175966 - Homo sapiens angiomotin-like protein 2 (AMOTL2) mRNA, partial cds.
AK291616 - Homo sapiens cDNA FLJ75874 complete cds, highly similar to Homo sapiens angiomotin like 2 (AMOTL2), mRNA.

Non-Human Aligned mRNA Search Results

DQ887096 - Danio rerio angiomotin-like 2 (amotl2) mRNA, complete cds.
BC163299 - Danio rerio angiomotin like 2, mRNA (cDNA clone MGC:194605 IMAGE:9038294), complete cds.
AF175967 - Mus musculus angiomotin-like protein 2 variant 1 (Amotl2) mRNA, partial cds.
AF175968 - Mus musculus angiomotin-like protein 2 variant 2 (Amotl2) mRNA, complete cds.
AF175969 - Rattus norvegicus angiomotin-like protein 2 (Amotl2) mRNA, partial cds.
BC027824 - Mus musculus angiomotin-like 2, mRNA (cDNA clone MGC:36419 IMAGE:5323888), complete cds.
BT026225 - Bos taurus angiomotin like 2 (AMOTL2), NotI truncated, mRNA, incomplete 5' and 3' cds.
JU334886 - TSA: Macaca mulatta Mamu_508517 mRNA sequence.